canceldeath
Registry update — unassessed

The Effectiveness of Smart Technology Interventions Combining Nutrition and Exercise for Older Adults at Risk of Sarcopenia

Trial registry update: COMPLETED. No results reported in the supplied registry record.

RCTN=60Minor significance
Reporter brief

What this changes

The finding has not established an approved change to our evidence assessment.

Source date: Oct 29, 2026 · Discovered: Oct 29, 2026 · Assessed: — · Research update

What it does not prove

  • The abstract contains no reported outcomes, effect sizes, or statistical findings, so it cannot demonstrate whether the intervention had any effect on muscle mass, strength, or quality of life.
  • This is a 12-week study, so it provides no evidence about long-term durability of any intervention benefit or sustained adherence to the technology platform.
  • Technology-assisted delivery alone cannot be isolated from the exercise and nutrition content itself; it is unclear whether benefits (if any) stem from the platform, the behavioral support, the exercise prescription, or their combination.

Extracted from supplied source material; model confidence is not a measured probability of correctness.

Design
Rct
Sample size
60
Duration
3 months
Population
Older adults at risk of sarcopenia, community-dwelling
Primary outcome
Muscle mass and physical performance in older adults at risk of sarcopenia
Effect size
—
Significance
Not reported
Journal
HSIAO MEI LAN
Published
Oct 29, 2026

Recorded source passages

Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.

This randomized controlled trial (RCT) will evaluate a 12-week smart-technology-based program for 60 older adults at risk of sarcopenia.
Participants in the intervention group will receive a technology-assisted program delivered through a Line Bot system. The platform provides personalized exercise training videos, nutrition education, daily reminders, and a point-based logging system to support adherence and monitor engagement. The control group will receive standard clinic-based care.
The study aims to examine whether the smart technology intervention can improve muscle mass, physical performance, quality of life, and self-management ability among older adults at risk of sarcopenia.

Assessment history

One thread per scientific event, no matter how many outlets covered it.

Sign in to join the discussion.

No comments yet

Be the first to weigh in on this evidence.